Megna M, Fornaro L, Potestio L, Luciano MA, Nocerino M, Delfino M, . . . Camela E. (2022). Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study. Dove Medical Press.
Chicago Style (17th ed.) CitationMegna M, Fornaro L, Potestio L, Luciano MA, Nocerino M, Delfino M, Guarino M, Fabbrocini G, and Camela E. Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study. Dove Medical Press, 2022.
MLA (9th ed.) CitationMegna M, et al. Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study. Dove Medical Press, 2022.
Warning: These citations may not always be 100% accurate.